WallStSmart

Quanta Services Inc (PWR)vsResMed Inc (RMD)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Quanta Services Inc generates 444% more annual revenue ($30.12B vs $5.54B). RMD leads profitability with a 27.4% profit margin vs 3.7%. RMD appears more attractively valued with a PEG of 1.26. RMD earns a higher WallStSmart Score of 73/100 (B).

PWR

Buy

54

out of 100

Grade: C-

Growth: 8.7Profit: 5.0Value: 3.7Quality: 5.0

RMD

Strong Buy

73

out of 100

Grade: B

Growth: 6.7Profit: 9.5Value: 5.3Quality: 8.3
Piotroski: 6/9Altman Z: 4.34
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for PWR.

RMDOvervalued (-13.5%)

Margin of Safety

-13.5%

Fair Value

$228.75

Current Price

$209.64

$19.11 premium

UndervaluedFair: $228.75Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

PWR3 strengths · Avg: 9.0/10
EPS GrowthGrowth
51.0%10/10

Earnings expanding 51.0% YoY

Market CapQuality
$113.65B9/10

Large-cap with strong market position

Revenue GrowthGrowth
26.3%8/10

Revenue surging 26.3% year-over-year

RMD4 strengths · Avg: 9.5/10
Operating MarginProfitability
35.3%10/10

Strong operational efficiency at 35.3%

Altman Z-ScoreHealth
4.3410/10

Safe zone — low bankruptcy risk

Return on EquityProfitability
25.3%9/10

Every $100 of equity generates 25 in profit

Profit MarginProfitability
27.4%9/10

Keeps 27 of every $100 in revenue as profit

Areas to Watch

PWR4 concerns · Avg: 3.5/10
PEG RatioValuation
2.434/10

Expensive relative to growth rate

Price/BookValuation
13.1x4/10

Trading at 13.1x book value

Profit MarginProfitability
3.7%3/10

3.7% margin — thin

Operating MarginProfitability
4.2%3/10

Operating margin of 4.2%

RMD0 concerns · Avg: 0/10

No major concerns identified

Comparative Analysis Report

WallStSmart Research

Bull Case : PWR

The strongest argument for PWR centers on EPS Growth, Market Cap, Revenue Growth. Revenue growth of 26.3% demonstrates continued momentum.

Bull Case : RMD

The strongest argument for RMD centers on Operating Margin, Altman Z-Score, Return on Equity. Profitability is solid with margins at 27.4% and operating margin at 35.3%. Revenue growth of 10.8% demonstrates continued momentum.

Bear Case : PWR

The primary concerns for PWR are PEG Ratio, Price/Book, Profit Margin. A P/E of 102.1x leaves little room for execution misses. Thin 3.7% margins leave little buffer for downturns.

Bear Case : RMD

No major red flags identified for RMD, but monitor valuation.

Key Dynamics to Monitor

PWR profiles as a growth stock while RMD is a mature play — different risk/reward profiles.

PWR carries more volatility with a beta of 1.24 — expect wider price swings.

PWR is growing revenue faster at 26.3% — sustainability is the question.

RMD generates stronger free cash flow (520M), providing more financial flexibility.

Bottom Line

RMD scores higher overall (73/100 vs 54/100), backed by strong 27.4% margins and 10.8% revenue growth. Both earn "Strong Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Quanta Services Inc

INDUSTRIALS · ENGINEERING & CONSTRUCTION · USA

Quanta Services is an American corporation that provides infrastructure services for electric power, pipeline, industrial and communications industries. Capabilities include the planning, design, installation, program management, maintenance and repair of most types of network infrastructure.

ResMed Inc

HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES · USA

ResMed is a San Diego, California-based medical equipment company. It primarily provides cloud-connectable medical devices for the treatment of sleep apnea (such as CPAP devices and masks), chronic obstructive pulmonary disease (COPD), and other respiratory conditions.

Visit Website →

Want to dig deeper into these stocks?